The Latest

Whether you're a patient, clinician, retailer or researcher, come with us as we work to bring quality, accessible cannabis care (and data) to all.

Featured

News

EO Data & Methodology: September 2026 Update

September 30, 2026

EO Team

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from people living with cancer who use cannabis to manage symptoms such as pain, sleep disturbance and anxiety, under the guidance of our clinical protocols.

News

EO Care Joins the Personify Health Partner Marketplace, Expanding Employer Access to Clinically Guided Cancer Symptom Management Solution

Employers using Personify Health can choose clinically responsible, evidence-based cannabinoid care to reduce unmanaged symptom burden, prescription reliance, and avoidable healthcare costs

Education

Meet the Advisor Q&A Series: 5 Questions with Maureen Sullvian

With decades of experience in healthcare strategy and innovation, Maureen Sullivan has spent her career helping organizations identify and scale solutions that improve care. Most recently, she served as Chief Strategy & Innovation Officer for the Blue Cross Blue Shield Association and advises innovative healthcare companies working to improve the quality and affordability of health care.

News

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.

Education

Can You Take Ibuprofen with Cannabis?

Discover how ibuprofen, CBD, and THC work for pain relief, whether they can be safely combined, and the dosing precautions for liver and stomach safety.

Education

Microdosing THC: Small Doses, Big Relief

Discover how microdosing THC delivers therapeutic relief without the high, what doses to start with, and which method fits pain, anxiety, sleep, or focus.

Education

Is It Safe to Mix Melatonin and Cannabis?

Discover how melatonin and low-dose THC work together for sleep, who should use them safely, and how to choose a balanced product without next-day grogginess.

Education

CBN vs CBD: Similar, But Not the Same

Discover the differences between CBN vs CBD, how each cannabinoid works in the body, and which one fits your needs for sleep, pain, or stress relief.

Education

CBC vs CBD

Discover the differences between CBC vs CBD, how each works in the body, when they may be most useful, and whether combining them makes sense for your needs.

Education

THC For Neuropathy

Discover how THC may help manage neuropathy symptoms, what forms of THC are commonly used, and how to approach cannabis care safely.

Education

How to Use Cannabis Tinctures: A Beginner’s Guide

Cannabis tinctures are one of the simplest ways to use THC or CBD, especially for people who want control, discretion, and predictable results. If you’re new to tinctures or unsure how to use them properly, this guide walks through the basics step by step. ‍You’ll learn what a cannabis tincture is, why people choose it, how to measure and take it correctly, and how to adjust your dosage safely over time.

News

EO Care, Inc. Statement on Cannabinoid Policy Announcements

The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.

News

EO Care, Inc. Statement on Proposed Federal Register Change

As the leader in cannabinoid based symptom management for older adults, we applaud the Centers for Medicare & Medicaid Services (CMS) proposal to expand coverage for federally legal, hemp-derived cannabinoid-based products. At EO, we are uniquely positioned to meet the need of this new, covered cannabinoid care market.

News

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also reported low rates of use-limiting side effects with further reductions after receiving updated recommended product and/or dosing guidance via EO Care’s digital care platform.

News

EO Launches Its Next Generation Cannabinoid Care Platform

New scalable, digital health offering makes personalized, clinically responsible cannabinoid guidance accessible to all older adults, adults in cancer treatment and cancer survivors.‍The platform was designed and tested with patients and clinicians at leading hospitals and NCI-Designated Cancer Centers.

The Latest

Featured

EO Data & Methodology: September 2026 Update

EO Care Joins the Personify Health Partner Marketplace, Expanding Employer Access to Clinically Guided Cancer Symptom Management Solution

Meet the Advisor Q&A Series: 5 Questions with Maureen Sullvian

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

Can You Take Ibuprofen with Cannabis?

Microdosing THC: Small Doses, Big Relief

Is It Safe to Mix Melatonin and Cannabis?

CBN vs CBD: Similar, But Not the Same

CBC vs CBD

THC For Neuropathy

How to Use Cannabis Tinctures: A Beginner’s Guide

EO Care, Inc. Statement on Cannabinoid Policy Announcements

EO Care, Inc. Statement on Proposed Federal Register Change

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

EO Launches Its Next Generation Cannabinoid Care Platform

EO in Your Inbox